Skip to main content
. 2004;6(Suppl 1):128–183. doi: 10.1080/16515320410016537
Oxaliplatin combination therapy 5-FU/FA alone
Average survival gain – base case (years) 9.0 1.7
Average survival gain – high resection rate (years) 9.0 1.7
Average survival gain – 0.75 survival (years) 7.3 1.7
Average survival gain – benefits discounted (years) 8.49 1.69
Cost per life year gained – base case (£) 11985
Cost per life year gained – high resection rate (£) 5489
Cost per life year gained – 0.75 survival (£) 15624
Cost per life year gained – benefits discounted (£) 12867